Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: Closing the 68Zn cycle

Applied Radiation and Isotopes

Volumn 70, Issue 3, 2012, Pages 423-429

  Medvedev, Dmitri G ^a   Mausner, Leonard F ^a   Meinken, George E ^a   Kurczak, Slawko O ^a   Schnakenberg, Henry ^a   Dodge, Cleveland J ^a   Korach, Elizabeth M ^a   Srivastava, Suresh C ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

BLIP; Chemical separation; Copper 67; High energy reaction; Radiotherapy; Zinc 68

Indexed keywords

BLIP; CHEMICAL SEPARATION; COPPER-67; HIGH ENERGY; ZINC-68;

ALUMINUM; COPPER; HIGH ENERGY PHYSICS; IRRADIATION; PRODUCTION; PROTONS; RADIOISOTOPES; RADIOTHERAPY; SEPARATION; TITANIUM;

ZINC;

ALUMINUM; COPPER 67; RADIOISOTOPE; TITANIUM; UNCLASSIFIED DRUG; ZINC 68;

ARTICLE; CONTROLLED STUDY; IRRADIATION; LARGE SCALE PRODUCTION; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; OXIDATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PRODUCT RECOVERY; PROTON ACCELERATOR; RADIOACTIVITY;

EID: 84855358508     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.10.007     Document Type: Article

References (29)

1. Al-Abyad M., Spahn I., Sudar S., Morsy M., Comsan M.N.H., Csikai J., Qaim S.M., Coenen H.H. Nuclear data for production of the therapeutic radionuclides P-32, Cu-64 Cu-67, Sr-89, Y-90 and Sm-153 via the (n,p) reaction: evaluation of excitation function and its validation via integral cross-section measurement using a 14MeV d(Be) neutron source. Appl. Radiat. Isot. 2006, 64(6):717-724.
2. Dasgupta A.K., Mausner L.F., Srivastava S.C. A new separation procedure for Cu-67 from proton irradiated Zn. Appl. Radiat. Isot. 1991, 42(4):371-376.
3. Delaloye A.B., Delaloye B., Buchegger F., Vogel C.-A., Gillet M., Mach J.-P., Smith A., Schubiger P.A. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors. J. Nucl. Med. 1997, 38(6):847-853.
4. Denardo G.L., Denardo S.J., Meares C.F., Salako Q., Kukis D.L., Mausner L.F., Lewis J.P., Ogrady L.F., Srivastava S.C. Pilot Therapy of Lymphoma with Fractionated Cu-67 Bat Lym-1. J. Nucl. Med. 1993, 34(5). P93-P93.
5. DeNardo S.J., DeNardo G.L., Kukis D.L., Shen S., Kroger L.A., DeNardo D.A., Goldstein D.S., Mirick G.R., Salako Q., Mausner L.F., Srivastava S.C., Meares C.F. 67Cu-21T-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma. J. Nucl. Med. 1999, 40(2):302-310.
6. Frier M. Rhenium-188 and copper-67 Radiopharmaceuticals for the treatment of bladder cancer. Mini-Rev. Med. Chem. 2004, 4(1):61-68.
7. Grunberg J., Novak-Hofer I., Honer M., Zimmermann K., Knogler K., Blauenstein P., Ametamey S., Maecke H.R., Schubiger P.A. In vivo evaluation of Lu-177- and Cu-67/64-labelled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors. Clin. Cancer Res. 2005, 11(14):5112-5120.
8. Hattink, J., Ponsard, B., Harms, A.V., De Boeck, G., Krijger, G.C., Blust, R., 2005. The production and use of Cu-67 as pharmacokinetic and toxicokinetic copper tracer via the Zn-67(n,p)Cu-67 reaction. In: Proceedings of the 5th International Conference on Isotopes. 5 ICI, April 25-29, Brussels, Belgium, p. 41.
9. Hilgers K., Stoll T., Skakun Y., Coenen H.H., Qaim S.M. Cross-section measurements of the nuclear reactions Zn-nat(d,x)Cu-64, Zn-66(d,alpha)Cu-64 and Zn-68(p,alpha n)Cu-64 for production of Cu-64 and technical developments for small-scale production of Cu-67 via the Zn-70(p,alpha)Cu-64 process. Appl. Radiat. Isot. 2003, 59(5-6):343-351.
10. Hughes O.D.M., Bishop M.C., Perkins A.C., Wastie M.L., Denton G., Price M.R., Frier M., Denley H., Rutherford R., Schubiger P.A. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595. J. Clin. Oncol. 2000, 18(2):363-370.
11. Jamriska D.J., Taylor W.A., Ott M.A., Heaton R.C., Phillips D.R., Fowler M.M. Activation rates and chemical recovery of Cu-67 produced with low-energy proton irradiation of enriched Zn-70 targets. J. Radioanal. Nucl. Chem. 1995, 195(2):263-270.
12. Kastleiner S., Coenen H.H., Qaim S.M. Possibility of production of Cu-67 at a small-sized cyclotron via the (p,alpha)-reaction on enriched Zn-70. Radiochim. Acta 1999, 84(2):107-110.
13. Katabuchi T., Watanabe S., Ishioka N.S., Iida Y., Hanaoka H., Endo K., Matsuhashi S. Production of Cu-67 via the Zn-68(p,2p)Cu-67 reaction and recovery of Zn-68 target. J. Radioanal. Nucl. Chem. 2008, 277(2):467-470.
14. Knogler K., Grunberg J., Zimmermann K., Cohrs S., Honer M., Ametamey S., Altevogt P., Fogel M., Schubiger P.A., Novak-Hofer I. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin. Cancer Res. 2007, 13(2):603-611.
15. Kraus K.A., Nelson F. Anion Exchange Studies of the Fission product. Ion exchange chromatography. Dowden 1955, 161-173. Hutchinson & Ross, Inc., Stroudsburg, PA. H.F. Walton (Ed.).
16. Mausner L.F., Kolsky K.L., Joshi V., Srivastava S.C. Radionuclide development at BNL for nuclear medicine therapy. Appl. Radiat. Isot. 1998, 49(4):285-294.
17. Mausner L.F., Medvedev D., Meinken G.E., Dodge C., Korach E., Srivastava S.C. Production of high specific activity Cu-67 with a large enriched Zn-68 target. J. Labelled Compd. Radiopharm. 2011, 54(S1):S236.
18. Mirick G.R., O'Donnell R.T., DeNardo S.J., Shen S., Meares C.F., DeNardo G.L. Transfer of copper from a chelated Cu-67-antibody conjugate to ceruloplasmin in lymphoma patients. Nucl. Med. Biol. 1999, 26(7):841-845.
19. Mirzadeh S., Mausner L.F., Srivastava S.C. Production of no-carrier added Cu-67. Appl. Radiat. Isot. 1986, 37(1):29-36.
20. Morrison D.L., Caretto A.A. Excitation Functions of (p,xp) Reactions. Phys. Rev. 1962, 127(5):1731-1738.
21. Novak-Hofer I., Schubiger P.A. Copper-67 as a therapeutic nuclide for radioimmunotherapy. Eur. J. Nucl. Med. Mol. Imag. 2002, 29(6):821-830.
22. O'Donnell R.T., DeNardo G.L., Kukis D.L., Lamborn K.R., Shen S., Yuan A.N., Goldstein D.S., Carr C.E., Mirick G.R., DeNardo S.J. A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma. J. Nucl. Med. 1999, 40(12):2014-2020.
23. Schwarzbach R., Zimmermann K., Blauenstein P., Smith A., Schubiger P.A. Development of a simple and selectiveseparation of Cu-67 from irradiated zinc for use in antibody labeling-a comparison of methods. Appl. Radiat. Isot. 1995, 46(5):329-336.
24. Steyn G.F., Mills S.J., Nortier F.M., Simpson B.R.S., Meyer B.R. Production of Fe-52 via proton-induced reactions on manganese and nickel. Appl. Radiat. Isot. 1990, 41(3):315-325.
25. Stoll T., Kastleiner S., Shubin Y.N., Coenen H.H., Qaim S.M. Excitation functions of proton induced reactions on Zn-68 from threshold up to 71MeV, with specific reference to the production Of Cu-67. Radiochim. Acta 2002, 90(6):309-313.
26. Szelecsenyi F., Steyn G.F., Kovacs Z., Vermeulen C., van der Meulen N.P., Dolley S.G., van der Walt T.N., Suzuki K., Mukai K. Investigation of the Zn-66(p,2pn)Cu-64 and Zn-68(p,x)Cu-64 nuclear processes up to 100MeV: production of Cu-64. Nucl. Instrum. Methods Phys. Res., Sect. B 2005, 240(3):625-637.
27. Szelecsenyi F., Steyn G.F., Dolley S.G., Kovacs Z., Vermeulen C., van der Walt T.N. Investigation of the Zn-68(p,2p)Cu-67 nuclear reaction: new measurements up to 40MeV and compilation up to 100MeV. Nucl. Instrum. Methods Phys. Res. Sect. B 2009, 267(11):1877-1881.
28. Ziegler, J.F.,Biersack, J.P.: The stopping and range of ions in matter (SRIM). http://www.srim.org/.
29. Zimmermann K., Grunberg J., Honer M., Ametamey S., Schubiger P.A., Novak-Hofer I. Targeting of renal carcinoma with Cu-67/64-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging. Nucl. Med. Biol. 2003, 30(4):417-427.